SERINA THERAPEUTICS, INC.

Profile

Company Names

SERINA THERAPEUTICS, INC.

Addresses

601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL 35806

601 GENOME WAY, SUITE 3400, HUNTSVILLE, AL 35806

Phone Numbers

2563270566

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

ALABAMA

Total Amount Raised:

$46,557,055.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2023-03-15 
$10,000,000.00 
$10,000,000.00 
$0.00 
Debt 
8
2022-11-10 
$3,650,000.00 
$3,650,000.00 
$0.00 
Debt 
7
2022-06-21 
$1,000,000.00 
$5,000,000.00 
$4,000,000.00 
Debt 
6
2019-07-01 
$3,681,009.00 
$76,230,000.00 
$72,548,991.00 
Equity 
5
2017-01-23 
$8,220,966.00 
$32,500,000.00 
$24,279,034.00 
Equity 
4
2014-04-11 
$4,855,000.00 
$6,250,000.00 
$1,395,000.00 
Equity 
3
2010-11-04 
$11,150,080.00 
$11,150,080.00 
$0.00 
Equity 
2
2008-03-01 
$2,000,000.00 
$2,000,000.00 
$0.00 
Equity 
1
2006-11-27 
$2,000,000.00 
$2,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GREG 
BAILEY, M.D. 
DIRECTOR
MICHAEL 
BENTLEY 
EXECUTIVE OFFICER, DIRECTOR
BARBARA 
 
FISK 
DIRECTOR
BARBARA 
FISK 
DIRECTOR
MILTON 
HARRIS 
EXECUTIVE OFFICER, DIRECTOR
JAMES 
HUDSON, JR. 
DIRECTOR
STEVE 
 
LEDGER 
DIRECTOR
MIGUEL 
LOYA 
DIRECTOR
LONNIE 
MCMILLIAN 
DIRECTOR
RANDALL 
MOREADITH 
EXECUTIVE OFFICER, DIRECTOR
BRENDAN 
 
RAE 
EXECUTIVE OFFICER
TACEY 
 
VIEGAS 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-03-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-11-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-06-21 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-01 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-01 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-01 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-01-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-01-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-01-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-01-23 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2014-04-11 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-11-04 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2008-03-01 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2006-11-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
TORREYA CAPITAL, A DIV OF FINANCIAL WEST INVESTMENT GROUP